Relating to a prescription drug purchasing pool for certain health benefit plan issuers and employers.
Summary
SB 2857 would require the Texas Health and Human Services Commission to establish a prescription drug purchasing pool for participating health benefit plan issuers, qualified public employers, and qualified private employers. The pool would allow these participants to buy prescription drugs for employees, dependents, and retirees at discounted rates or under terms negotiated by the commission. The bill also authorizes the commission to negotiate optional stop-loss coverage for participants and allows two or more participants to jointly purchase drugs through the pool.
The bill specifies that the pool is not a risk pool and does not create a multiple employer welfare arrangement under Texas insurance law. Each participant remains responsible for paying claims or prescription drug costs under its own health benefit coverage arrangements. The executive commissioner would be required to adopt rules governing eligibility, enrollment, contributions, disenrollment, and other administrative details. The bill is set to take effect September 1, 2025, and implementation is contingent on appropriated funding, though HHSC may use other available money if it chooses.
Impact
SB 2857 would add a new Chapter 446 to the Texas Health and Safety Code and direct HHSC to create and administer a state-run prescription drug purchasing pool. It would affect health benefit plan issuers, self-insured private employers, and public employers such as counties, municipalities, school districts, universities, and quasi-public agencies, as well as their employees, dependents, and retirees. The bill also clarifies that participating arrangements are not risk pools or multiple employer welfare arrangements, which limits how the new purchasing structure is treated under existing insurance law.
Sentiment
The available voting history suggests the bill had meaningful support in the Senate, passing key procedural and final floor votes 27-4. That margin indicates broad approval among senators, with only a small minority opposed. No committee transcript is available here, so the record does not show detailed debate, but the vote pattern suggests the bill was generally viewed favorably as a cost-saving prescription drug measure.
Contention
The main points of potential contention are likely to be the role of the state in negotiating drug purchasing terms, the administrative burden on HHSC, and whether the pool could affect existing employer or insurer arrangements. The bill’s explicit statement that the pool is not a risk pool and not a multiple employer welfare arrangement appears designed to address legal and regulatory concerns. Another possible issue is funding, since implementation is required only if the legislature appropriates money specifically for that purpose, leaving the commission discretion to proceed only if other funds are available.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for r . . .estocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.